Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage

This publication has 33 references indexed in Scilit:

• Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis
  Antimicrobial Agents and Chemotherapy, 2005
• Interactions of Toll-like receptors with fungi
  Microbes and Infection, 2004
• Cryptococcal Yeast Cells Invade the Central Nervous System via Transcellular Penetration of the Blood-Brain Barrier
  Infection and Immunity, 2004
• Role of Extracellular Phospholipases and Mononuclear Phagocytes in Dissemination of Cryptococcosis in a Murine Model
  Infection and Immunity, 2004
• Cell wall α‐1,3‐glucan is required to anchor the Cryptococcus neoformans capsule
  Molecular Microbiology, 2003
• ‘Ready made’ virulence and ‘dual use’ virulence factors in pathogenic environmental fungi — the Cryptococcus neoformans paradigm
  Current Opinion in Microbiology, 2003
• A Yeast under Cover: the Capsule ofCryptococcus neoformans
  Eukaryotic Cell, 2003
• Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection
  Infection and Immunity, 2001
• PersistentCryptococcus neoformansPulmonary Infection in the Rat Is Associated with Intracellular Parasitism, Decreased Inducible Nitric Oxide Synthase Expression, and Altered Antibody Responsiveness to Cryptococcal Polysaccharide
  Infection and Immunity, 2000
• Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.
  The Journal of Experimental Medicine, 1991